0001437749-23-029920.txt : 20231102 0001437749-23-029920.hdr.sgml : 20231102 20231102103851 ACCESSION NUMBER: 0001437749-23-029920 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20231030 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231102 DATE AS OF CHANGE: 20231102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO KEY INTERNATIONAL INC CENTRAL INDEX KEY: 0001019034 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 411761861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13463 FILM NUMBER: 231370603 BUSINESS ADDRESS: STREET 1: 101 CRAWFORDS CORNER RD STREET 2: SUITE 4116 CITY: HOLMDEL STATE: NJ ZIP: 07733 BUSINESS PHONE: 7323591100 MAIL ADDRESS: STREET 1: 101 CRAWFORDS CORNER RD STREET 2: SUITE 4116 CITY: HOLMDEL STATE: NJ ZIP: 07733 FORMER COMPANY: FORMER CONFORMED NAME: SAC TECHNOLOGIES INC DATE OF NAME CHANGE: 19961115 8-K 1 bkyi20231101_8k.htm FORM 8-K bkyi20231101_8k.htm
false 0001019034 0001019034 2023-10-30 2023-10-30
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 30, 2023
 
BIO-key International, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)
1-13463
(Commission File Number)
41-1741861
(I.R.S. Employer Identification No.)
 
101 Crawfords Corner Road
Suite 4116
Holmdel, NJ 07733
(Address of principal executive offices) (Zip Code)
 
(732) 359-1100
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
BKYI
Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
 
   
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 1.01         Entry into a Material Definitive Agreement.
 
On October 30, 2023, BIO-key International, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors in connection with a public offering of the Company’s securities (the “Offering”). At the closing of Offering on October 31, 2023, the Company issued and sold 21,430,000 units (the “Units”), consisting of 4,230,000 share of common stock, par value $0.0001 per share (the “Common Stock”), 17,200,000 pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), and 21,430,000 warrants to purchase share of Common Stock (the “Common Warrants” and, together with the Pre-Funded Warrants, the “Warrants”). Each Unit was sold at a public offering price of $0.175. The Common Warrants are immediately exercisable at an exercise price of $0.175 per share and expire on the five-year anniversary of the date of issuance. The Pre-Funded Warrants are immediately exercisable at an exercise price of $0.001 per share.
 
The Offering was made pursuant to the Company’s Registration Statement on Form S-1, as amended (File No. 333-275003), which was declared effective by the Securities and Exchange Commission (the “SEC”) on October 30, 2023. The final prospectus relating to the offering was filed with the SEC on October 31, 2023 and may be obtained from the SEC’s website at http://www.sec.gov or from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, at (212) 895-3745.
 
The net proceeds from the offering were approximately $3.3 million, after deducting the placement agent fees and offering expenses. The Company intends to use the net proceeds from the offering to repay up to $2.2 million of outstanding indebtedness and for general corporate and working capital purposes to fund ongoing operations and expansion of the business.
 
On October 30, 2023, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC to serve as its exclusive placement agent in connection with the Offering. Pursuant to the terms of the Placement Agency Agreement, the Company paid a cash fee to Maxim Group LLC equal to 7.0% of the gross proceeds received by the Company from the sale of the securities in Offering, as well as reimbursement for certain expenses.
 
The Warrants are immediately exercisable and will expire five years from the date of issuance. The Warrants contain standard and customary adjustments to the exercise price including for stock splits, stock dividends, rights offerings and pro rata distributions and standard and customary rights upon “fundamental transactions” (as described in the Warrants). The Warrants include cashless exercise rights to the extent the shares of Common Stock underlying the Warrants are not registered under the Securities Act of 1933, as amended (the “Securities Act”).
 
Under the terms of the Warrants, a holder will not be entitled to exercise any portion of any such Warrant, if, upon giving effect to such exercise, the aggregate number of shares of Common Stock beneficially owned by the holder (together with its affiliates and any other person whose beneficial ownership of Common Stock would or could be aggregated with the holder’s) would exceed 4.99% or 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased at the holder’s election upon 61 days’ notice to the Company subject to the terms of such warrants, provided that such percentage may in no event exceed 9.99%.
 
Simultaneously with the closing of the Offering, the Company entered into a warrant agency agreement (the “Warrant Agency Agreement”) with Broadridge Corporate Issuer Solutions, LLC (“Broadridge”), pursuant to which Broadridge will act as warrant agent with respect to the Warrants issued by the Company in the Offering.
 
 
 
 
The representations, warranties and covenants contained in the Purchase Agreement, Placement Agency Agreement and Warrant Agency Agreement were made solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Purchase Agreement, Placement Agency Agreement and Warrant Agency Agreement are incorporated herein by reference only to provide investors with information regarding the terms of such agreements, and not to provide investors with any other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s periodic reports and other filings with the SEC.
 
The foregoing descriptions of the Purchase Agreement, Common Warrants, Pre-Funded Warrants, Placement Agency Agreement, and Warrant Agency Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the form of Purchase Agreement, Common Warrants, Pre-Funded Warrants, Placement Agency Agreement, and Warrant Agency Agreement which are filed as Exhibits 10.1, 4.1 4.2, 1.1, and 4.3, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
 
Item 7.01         Regulation FD Disclosure.
 
On October 30, 2023, the Company issued a press release announcing the pricing of the Units in the Offering. On October 31, 2023, the Company issued a press release announcing the closing of the Offering. Copies of the press releases are attached to this Form 8-K as Exhibit 99.1 and Exhibit 99.2, respectively.
 
In accordance with General Instruction B.2 of Form 8-K, the information furnished under this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act except as shall be expressly set forth by specific reference in such a filing.
 
Item 9.01         Financial Statements and Exhibits.
 
(d) 
Exhibits
1.1
   
4.1
   
4.2
   
4.3
   
10.1
   
99.1
   
99.2
   
104
Cover Page Interactive Data File (embedded with the Inline XBRL document)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BIO-KEY INTERNATIONAL, INC.
  
Date: November 2, 2023
      
 
By:
/s/ Cecilia C. Welch
  
   
Cecilia C. Welch
  
   
Chief Financial Officer
  
 
 
 EX-99.1 2 ex_589969.htm EXHIBIT 99.1 ex_589969.htm

Exhibit 99.1

 

logo.jpg

 

BIO-key International Announces Pricing of $3.75 Million Public Offering

 

Holmdel, NJ – October 30, 2023 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the pricing of its public offering of 21,430,000 units, with each unit consisting of one share of common stock (or a pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. Each unit is being sold at a public offering price of $0.175. The warrants in each unit will be immediately exercisable at a price of $0.175 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and the accompanying warrants can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance.

 

Gross proceeds, before deducting placement agent fees and estimated offering expenses, are expected to be approximately $3.75 million. The offering is expected to close on October 31, 2023, subject to customary closing conditions.

 

Maxim Group LLC is acting as sole placement agent in connection with this offering.

 

The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-275003), which was declared effective by the Securities and Exchange Commission (the "SEC") on October 30, 2023. The offering is being made only by means of a prospectus, which is a part of the effective registration statement. A preliminary prospectus relating to the offering has been filed with the SEC. Copies of the final prospectus relating to this offering, when available, will be filed with the SEC and may be obtained from Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, at (212) 895-3745.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

 

About BIO-key International, Inc.

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to devices, information, applications, and high-value transactions. With industry-leading Identity-Bound Biometric (IBB) capabilities, BIO-key's patented software and hardware solutions enable large-scale Identity-as-a-Service (IDaaS) solutions and customized on-premises solutions. BIO-key EMEA (formerly Swivel Secure Europe, S.A.) is an IAM solutions provider based in Madrid, Spain, that serves the European, Middle East, and African markets.

 

 
 

 

Forward Looking Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

 

Engage with BIO-key:

 

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/

LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international

Twitter – Corporate: @BIOkeyIntl

Twitter – Investors: @BIO_keyIR

StockTwits: BIO_keyIR

 

Investor Contacts:

William Jones, David Collins

Catalyst IR

BKYI@catalyst-ir.com

212-924-9800

 

 
 EX-99.2 3 ex_589970.htm EXHIBIT 99.2 ex_589970.htm

Exhibit 99.2

 

logo.jpg

 

BIO-key International Announces Closing of $3.75 Million Public Offering

 

Holmdel, NJ – October 31, 2023 - BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication solutions, today announced the closing of its previously announced public offering of 21,430,000 units, with each unit consisting of one share of common stock (or a pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.175. The warrants will be immediately exercisable at a price of $0.175 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants could only be purchased together in the offering but were issued separately and were immediately separable upon issuance.

 

Gross proceeds, before deducting placement agent fees and estimated offering expenses, were approximately $3.75 million.

 

Maxim Group LLC acted as sole placement agent in connection with this offering.

 

The securities described above were offered pursuant to a registration statement on Form S-1 (File No. 333-275003), which was declared effective by the Securities and Exchange Commission (the "SEC") on October 30, 2023. A final prospectus relating to the offering was filed with the SEC on October 31, 2023 and is available on the SEC’s website at http://www.sec.gov. Electronic copies of the final prospectus relating to this offering may be obtained from 300 Park Avenue, 16th Floor, New York, New York 10022, at (212) 895-3745.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

About BIO-key International, Inc.

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to devices, information, applications, and high-value transactions. With industry-leading Identity-Bound Biometric (IBB) capabilities, BIO-key's patented software and hardware solutions enable large-scale Identity-as-a-Service (IDaaS) solutions and customized on-premises solutions. BIO-key EMEA (formerly Swivel Secure Europe, S.A.) is an IAM solutions provider based in Madrid, Spain, that serves the European, Middle East, and African markets.

 

 
 

 

Forward Looking Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy debt repayment obligations and working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of Swivel Secure into our business; fluctuations in foreign currency exchange rates; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.

 

Engage with BIO-key:

 

Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/

LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international

Twitter – Corporate: @BIOkeyIntl

Twitter – Investors: @BIO_keyIR

StockTwits: BIO_keyIR

 

Investor Contacts:

William Jones, David Collins

Catalyst IR

BKYI@catalyst-ir.com

212-924-9800

 

 
 EX-101.SCH 4 bkyi-20231030.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 5 bkyi-20231030_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 bkyi-20231030_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, Address Line Two Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 7 bkyi-20231030_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 logo.jpg begin 644 logo.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information
Oct. 30, 2023
Document Information [Line Items]  
Entity, Registrant Name BIO-key International, Inc.
Document, Type 8-K
Document, Period End Date Oct. 30, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 1-13463
Entity, Tax Identification Number 41-1741861
Entity, Address, Address Line One 101 Crawfords Corner Road
Entity, Address, Address Line Two Suite 4116
Entity, Address, City or Town Holmdel
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 07733
City Area Code 732
Local Phone Number 359-1100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol BKYI
Security Exchange Name NASDAQ
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001019034
XML 10 bkyi20231101_8k_htm.xml IDEA: XBRL DOCUMENT 0001019034 2023-10-30 2023-10-30 false 0001019034 8-K 2023-10-30 BIO-key International, Inc. DE 1-13463 41-1741861 101 Crawfords Corner Road Suite 4116 Holmdel NJ 07733 732 359-1100 false false false false Common Stock BKYI NASDAQ false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'-02P$"% ,4 " #85&)799!YDAD! #/ P $P M@ &W$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" !% " ! end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.bkyi.com/20231030/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports bkyi-20231030.xsd bkyi-20231030_def.xml bkyi-20231030_lab.xml bkyi-20231030_pre.xml bkyi20231101_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bkyi20231101_8k.htm": { "nsprefix": "bkyi", "nsuri": "http://www.bkyi.com/20231030", "dts": { "schema": { "local": [ "bkyi-20231030.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "bkyi-20231030_def.xml" ] }, "labelLink": { "local": [ "bkyi-20231030_lab.xml" ] }, "presentationLink": { "local": [ "bkyi-20231030_pre.xml" ] }, "inline": { "local": [ "bkyi20231101_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 27, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.bkyi.com/20231030/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "bkyi20231101_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20238K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "bkyi20231101_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.bkyi.com/20231030/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-23-029920-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-029920-xbrl.zip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end